A new definition and refocus of pharmaceutical care: the Barbate Document

Objective: To propose an updated definition of Pharmaceutical Care based on the Capacity-Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its development that guarantee the highest levels of quality and excellence in this professional activity. Method: The co...

Full description

Saved in:
Bibliographic Details
Main Authors: Ramón Morillo-Verdugo, José Luis Poveda-Andrés, María de las Aguas Robustillo-Cortés, Miguel Ángel Calleja-Hernández
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/11389.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846093671234011136
author Ramón Morillo-Verdugo
José Luis Poveda-Andrés
María de las Aguas Robustillo-Cortés
Miguel Ángel Calleja-Hernández
author_facet Ramón Morillo-Verdugo
José Luis Poveda-Andrés
María de las Aguas Robustillo-Cortés
Miguel Ángel Calleja-Hernández
author_sort Ramón Morillo-Verdugo
collection DOAJ
description Objective: To propose an updated definition of Pharmaceutical Care based on the Capacity-Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its development that guarantee the highest levels of quality and excellence in this professional activity. Method: The consensus was developed by a working group composed of members of the Spanish Society of Hospital Pharmacy and other pharmacists from different healthcare fields. A literature review of PubMed was conducted of the available scientific evidence on pharmaceutical healthcare models and activities with the greatest impact and ease of implementation. A working definition was developed and the initiatives chosen as key elements were collected and included in each pillar of the proposed model. After creating an initial list of activities and terms, the working group reviewed it and made corrections or proposed new activities. In addition, the definitions of the three key elements of the CMO model were agreed upon: Capacity-Motivation- Opportunity. In order to incorporate all appropriate suggestions and contributions before finalizing the consensus, the final draft was sent to the different scientific, pharmaceutical, and medical societies as well as patient associations with which the Spanish Society of Hospital Pharmacy has a collaboration agreement. Results: The definition of consensual Pharmaceutical Care was “Any professional activity by which the pharmacist is linked to the patient (and/or caregiver) and other healthcare professionals, to attend to the patient according to their needs, setting out strategies to align and achieve the shortand medium-/long-term objectives of pharmacotherapy and incorporating new technologies and the means available to continuously interact with ment was reached on the definitions of the three key elements of the CMO model. Finally, 27 key elements for the development of pharmaceutical activity were identified and included in the three pillars of the model. Conclusions: A new definition of Pharmaceutical Care has been agreed upon that refocuses this professional activity, allowing us to advance within the multidisciplinary working approach toward a longitudinal and multidimensional approach to the patient.
format Article
id doaj-art-d040832cad6d46e18f5c7989b5eef5fd
institution Kabale University
issn 1130-6343
2171-8695
language English
publishDate 2020-07-01
publisher Elsevier
record_format Article
series Farmacia Hospitalaria
spelling doaj-art-d040832cad6d46e18f5c7989b5eef5fd2025-01-02T16:48:25ZengElsevierFarmacia Hospitalaria1130-63432171-86952020-07-0144415816210.7399/fh.11389A new definition and refocus of pharmaceutical care: the Barbate DocumentRamón Morillo-Verdugo0José Luis Poveda-Andrés1María de las Aguas Robustillo-Cortés2Miguel Ángel Calleja-Hernández3Servicio de Farmacia Hospitalaria, Hospital Universitario Virgen de Valme, Área de Gestión Sanitaria Sur de Sevilla, Sevilla. SpainServicio de Farmacia Hospitalaria, Hospital Universitario La Fe, Valencia. SpainServicio de Farmacia Hospitalaria, Hospital Universitario Virgen de Valme, Área de Gestión Sanitaria Sur de Sevilla, Sevilla. SpainServicio de Farmacia, Hospital Virgen Macarena, Sevilla. SpainObjective: To propose an updated definition of Pharmaceutical Care based on the Capacity-Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its development that guarantee the highest levels of quality and excellence in this professional activity. Method: The consensus was developed by a working group composed of members of the Spanish Society of Hospital Pharmacy and other pharmacists from different healthcare fields. A literature review of PubMed was conducted of the available scientific evidence on pharmaceutical healthcare models and activities with the greatest impact and ease of implementation. A working definition was developed and the initiatives chosen as key elements were collected and included in each pillar of the proposed model. After creating an initial list of activities and terms, the working group reviewed it and made corrections or proposed new activities. In addition, the definitions of the three key elements of the CMO model were agreed upon: Capacity-Motivation- Opportunity. In order to incorporate all appropriate suggestions and contributions before finalizing the consensus, the final draft was sent to the different scientific, pharmaceutical, and medical societies as well as patient associations with which the Spanish Society of Hospital Pharmacy has a collaboration agreement. Results: The definition of consensual Pharmaceutical Care was “Any professional activity by which the pharmacist is linked to the patient (and/or caregiver) and other healthcare professionals, to attend to the patient according to their needs, setting out strategies to align and achieve the shortand medium-/long-term objectives of pharmacotherapy and incorporating new technologies and the means available to continuously interact with ment was reached on the definitions of the three key elements of the CMO model. Finally, 27 key elements for the development of pharmaceutical activity were identified and included in the three pillars of the model. Conclusions: A new definition of Pharmaceutical Care has been agreed upon that refocuses this professional activity, allowing us to advance within the multidisciplinary working approach toward a longitudinal and multidimensional approach to the patient.http://www.aulamedica.es/fh/pdf/11389.pdfpharmaceutical carepharmacypatient outcomes assessmenthealthcare deliveryclinical pharmacy servicepharmacisthospital pharmacy service
spellingShingle Ramón Morillo-Verdugo
José Luis Poveda-Andrés
María de las Aguas Robustillo-Cortés
Miguel Ángel Calleja-Hernández
A new definition and refocus of pharmaceutical care: the Barbate Document
Farmacia Hospitalaria
pharmaceutical care
pharmacy
patient outcomes assessment
healthcare delivery
clinical pharmacy service
pharmacist
hospital pharmacy service
title A new definition and refocus of pharmaceutical care: the Barbate Document
title_full A new definition and refocus of pharmaceutical care: the Barbate Document
title_fullStr A new definition and refocus of pharmaceutical care: the Barbate Document
title_full_unstemmed A new definition and refocus of pharmaceutical care: the Barbate Document
title_short A new definition and refocus of pharmaceutical care: the Barbate Document
title_sort new definition and refocus of pharmaceutical care the barbate document
topic pharmaceutical care
pharmacy
patient outcomes assessment
healthcare delivery
clinical pharmacy service
pharmacist
hospital pharmacy service
url http://www.aulamedica.es/fh/pdf/11389.pdf
work_keys_str_mv AT ramonmorilloverdugo anewdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT joseluispovedaandres anewdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT mariadelasaguasrobustillocortes anewdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT miguelangelcallejahernandez anewdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT ramonmorilloverdugo newdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT joseluispovedaandres newdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT mariadelasaguasrobustillocortes newdefinitionandrefocusofpharmaceuticalcarethebarbatedocument
AT miguelangelcallejahernandez newdefinitionandrefocusofpharmaceuticalcarethebarbatedocument